Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2012

01-04-2012 | Educational Series/Red Series

Lynch syndrome diagnostics: decision-making process for germ-line testing

Authors: Enrique Lastra, María García-González, Beatriz Llorente, Coralina Bernuy, M. Jesús Barrio, Lucía Pérez-Cabornero, Mercedes Durán, Carlos García-Girón

Published in: Clinical and Translational Oncology | Issue 4/2012

Login to get access
Metadata
Title
Lynch syndrome diagnostics: decision-making process for germ-line testing
Authors
Enrique Lastra
María García-González
Beatriz Llorente
Coralina Bernuy
M. Jesús Barrio
Lucía Pérez-Cabornero
Mercedes Durán
Carlos García-Girón
Publication date
01-04-2012
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0793-3

Other articles of this Issue 4/2012

Clinical and Translational Oncology 4/2012 Go to the issue

Research Articles

Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement

Research Articles

Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma

Research Articles

Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol

Educational Series/Blue Series

Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities

Correspondence

Prophylactic cranial irradiation: the state of the art and areas of uncertainty

Research Articles

Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits